Efficacy and safety of biological agents for the treatment of pediatric patients with psoriasis: A bayesian analysis of six high-quality randomized controlled trials

MLA

Xiao-ce Cai, et al. “Efficacy and Safety of Biological Agents for the Treatment of Pediatric Patients with Psoriasis: A Bayesian Analysis of Six High-Quality Randomized Controlled Trials.” Frontiers in Immunology, vol. 13, Aug. 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.896550.

APA

Xiao-ce Cai, Yi Ru, Liu Liu, Xiao-ying Sun, Ya-qiong Zhou, Ying Luo, Jia-le Chen, Miao Zhang, Chun-xiao Wang, Bin Li, & Xin Li. (2022). Efficacy and safety of biological agents for the treatment of pediatric patients with psoriasis: A bayesian analysis of six high-quality randomized controlled trials. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.896550

Chicago

Xiao-ce Cai, Yi Ru, Liu Liu, Xiao-ying Sun, Ya-qiong Zhou, Ying Luo, Jia-le Chen, et al. 2022. “Efficacy and Safety of Biological Agents for the Treatment of Pediatric Patients with Psoriasis: A Bayesian Analysis of Six High-Quality Randomized Controlled Trials.” Frontiers in Immunology 13 (August). doi:10.3389/fimmu.2022.896550.